Cardiac Guidance vs Eko Low Ejection Fraction Tool (ELEFT)

Tool A (Cardiac Guidance) offers a greater leap in usability by simplifying the highly complex procedure of cardiac ultrasound acquisition for non-expert users through real-time, turn-by-turn AI guidance and automated quality assessment. This significantly lowers the barrier to performing a technically demanding diagnostic procedure. Tool B (ELEFT) enhances a simpler screening process with quick results, which is valuable but less transformative in terms of user skill requirement.

Tool A (Cardiac Guidance) provides higher clinical value by enabling the acquisition of diagnostic-quality cardiac ultrasound images and automated left ventricular ejection fraction (EF) calculation, offering a more comprehensive and detailed assessment of cardiac structure and function. Tool B (ELEFT) is a valuable screening tool for early detection of low EF and heart failure risk, but its scope is more focused on risk identification rather than full diagnostic imaging.

Tool B (ELEFT), as part of Eko's SENSORAu2122 platform, demonstrates clearer pricing value through established CMS reimbursement, with a specific national payment rate of $128.90 per use for hospital outpatient settings, effective July 2025. While Tool A (Cardiac Guidance) has secured CMS New Technology Add-on Payment (NTAP) status, its direct enterprise software pricing remains opaque, making a direct value comparison difficult without more specific information.

Tool B (ELEFT) is explicitly positioned as part of Eko's SENSORAu2122 'enterprise solution' and platform, with a dedicated enterprise help center and established CMS reimbursement pathways for widespread clinical adoption. While Tool A (Cardiac Guidance) benefits from being part of GE HealthCare, Tool B's explicit platform approach and clear reimbursement structure indicate a more mature and defined enterprise readiness.

Tool A (Cardiac Guidance) represents a more significant innovation by making a traditionally complex and skill-intensive diagnostic imaging procedure (cardiac ultrasound) accessible to a broader range of healthcare professionals through real-time AI guidance. This addresses a fundamental barrier to access for critical cardiac assessments. Tool B's innovation is valuable in enhancing a routine physical exam, but Tool A's impact on democratizing a specialized skill is arguably greater.

Tool B (Eko Health) provides a more robust and transparent support framework, including distinct help centers for different customer types (individual vs. enterprise), clearly defined support hours, multiple contact methods (phone, email, chat), and documented service level agreements for enterprise clients. Tool A's support details are less explicit, though a related product's documentation suggests comprehensive options.